{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:25:41Z","timestamp":1777879541344,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ5551"],"award-info":[{"award-number":["2024JJ5551"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82101789"],"award-info":[{"award-number":["82101789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Special Project of National Clinical Key Specialties of the Health Commission of Hunan Province","award":["Z2023015"],"award-info":[{"award-number":["Z2023015"]}]},{"name":"General Project of the Health Commission of Hunan Province","award":["B202305026242"],"award-info":[{"award-number":["B202305026242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10495-026-02328-9","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:03:55Z","timestamp":1774199035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted delivery of RGD-JEG-3-EVs for placental vascular regeneration in preeclampsia: from molecular mechanism toward therapy"],"prefix":"10.1007","volume":"31","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee LA, Nicolaides KH, von Dadelszen P (2022) Preeclampsia. N Engl J Med 386:1817\u20131832. https:\/\/doi.org\/10.1056\/NEJMra2109523","journal-title":"N Engl J Med"},{"key":"2328_CR2","doi-asserted-by":"publisher","unstructured":"Collaborators, G. B. D. M. M (2016) Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 1775-1812. https:\/\/doi.org\/10.1016\/S0140-6736(16)31470-2","DOI":"10.1016\/S0140-6736(16)31470-2"},{"key":"2328_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.111.00250","volume":"61","author":"AC Staff","year":"2013","unstructured":"Staff AC et al (2013) Redefining preeclampsia using placenta-derived biomarkers. Hypertension 61:932\u2013942. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00250","journal-title":"Hypertension"},{"key":"2328_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 124:1094\u20131112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"key":"2328_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ceb.2020.08.010","volume":"67","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Yan L, Liang X, Wang H (2020) Progress in deciphering trophoblast cell differentiation during human placentation. Curr Opin Cell Biol 67:86\u201391. https:\/\/doi.org\/10.1016\/j.ceb.2020.08.010","journal-title":"Curr Opin Cell Biol"},{"key":"2328_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189675","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wong RJ, Stevenson DK (2021) The impact of hypoxia in early pregnancy on placental cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22189675","journal-title":"Int J Mol Sci"},{"key":"2328_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051496","author":"R Aouache","year":"2018","unstructured":"Aouache R, Biquard L, Vaiman D, Miralles F (2018) Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051496","journal-title":"Int J Mol Sci"},{"key":"2328_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.placenta.2010.08.011","volume":"31","author":"M Bilban","year":"2010","unstructured":"Bilban M et al (2010) Trophoblast invasion: assessment of cellular models using gene expression signatures. Placenta 31:989\u2013996. https:\/\/doi.org\/10.1016\/j.placenta.2010.08.011","journal-title":"Placenta"},{"key":"2328_CR9","doi-asserted-by":"publisher","first-page":"e05096","DOI":"10.1016\/j.heliyon.2020.e05096","volume":"6","author":"C Martinez","year":"2020","unstructured":"Martinez C et al (2020) Isthmin 2 is decreased in preeclampsia and highly expressed in choriocarcinoma. Heliyon 6:e05096. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05096","journal-title":"Heliyon"},{"key":"2328_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fphar.2014.00175","volume":"5","author":"C Salomon","year":"2014","unstructured":"Salomon C et al (2014) Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration. Front Pharmacol 5:175. https:\/\/doi.org\/10.3389\/fphar.2014.00175","journal-title":"Front Pharmacol"},{"key":"2328_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. https:\/\/doi.org\/10.3390\/cells8070727","journal-title":"Cells"},{"key":"2328_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B (2018) Exosome theranostics: biology and translational medicine. Theranostics 8:237\u2013255. https:\/\/doi.org\/10.7150\/thno.21945","journal-title":"Theranostics"},{"key":"2328_CR13","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.7150\/thno.62330","volume":"11","author":"M Xu","year":"2021","unstructured":"Xu M et al (2021) Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics 11:8926\u20138944. https:\/\/doi.org\/10.7150\/thno.62330","journal-title":"Theranostics"},{"key":"2328_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-019-0461-7","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H et al (2019) Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnol 17:29. https:\/\/doi.org\/10.1186\/s12951-019-0461-7","journal-title":"J Nanobiotechnol"},{"key":"2328_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","volume":"356","author":"L Nieland","year":"2023","unstructured":"Nieland L, Mahjoum S, Grandell E, Breyne K, Breakefield XO (2023) Engineered EVs designed to target diseases of the CNS. J Control Release 356:493\u2013506. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.009","journal-title":"J Control Release"},{"key":"2328_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","volume":"353","author":"J Mondal","year":"2023","unstructured":"Mondal J et al (2023) Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release 353:1127\u20131149. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.027","journal-title":"J Control Release"},{"key":"2328_CR17","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J (2021) Engineering exosomes for targeted drug delivery. Theranostics 11:3183\u20133195. https:\/\/doi.org\/10.7150\/thno.52570","journal-title":"Theranostics"},{"key":"2328_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2741\/s448","volume":"8","author":"LA Burnett","year":"2016","unstructured":"Burnett LA, Nowak RA (2016) Exosomes mediate embryo and maternal interactions at implantation and during pregnancy. Front Biosci (Schol Ed) 8:79\u201396. https:\/\/doi.org\/10.2741\/s448","journal-title":"Front Biosci (Schol Ed)"},{"key":"2328_CR19","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z et al (2018) Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun 9:5395. https:\/\/doi.org\/10.1038\/s41467-018-07810-w","journal-title":"Nat Commun"},{"key":"2328_CR20","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.7150\/thno.84971","volume":"13","author":"Q Li","year":"2023","unstructured":"Li Q, Fu X, Kou Y, Han N (2023) Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue. Theranostics 13:4266\u20134286. https:\/\/doi.org\/10.7150\/thno.84971","journal-title":"Theranostics"},{"key":"2328_CR21","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.2174\/092986712800784748","volume":"19","author":"D Arosio","year":"2012","unstructured":"Arosio D, Casagrande C, Manzoni L (2012) Integrin-mediated drug delivery in cancer and cardiovascular diseases with peptide-functionalized nanoparticles. Curr Med Chem 19:3128\u20133151. https:\/\/doi.org\/10.2174\/092986712800784748","journal-title":"Curr Med Chem"},{"key":"2328_CR22","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1021\/mp3002733","volume":"9","author":"F Danhier","year":"2012","unstructured":"Danhier F, Le Breton A, Preat V (2012) RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9:2961\u20132973. https:\/\/doi.org\/10.1021\/mp3002733","journal-title":"Mol Pharm"},{"key":"2328_CR23","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.7150\/thno.56367","volume":"11","author":"T Tian","year":"2021","unstructured":"Tian T et al (2021) Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics 11:6507\u20136521. https:\/\/doi.org\/10.7150\/thno.56367","journal-title":"Theranostics"},{"key":"2328_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/ajh\/hpx063","volume":"30","author":"SC Cushen","year":"2017","unstructured":"Cushen SC, Goulopoulou S (2017) New models of pregnancy-associated hypertension. Am J Hypertens 30:1053\u20131062. https:\/\/doi.org\/10.1093\/ajh\/hpx063","journal-title":"Am J Hypertens"},{"key":"2328_CR25","doi-asserted-by":"publisher","first-page":"1168173","DOI":"10.3389\/fped.2023.1168173","volume":"11","author":"N Nakamura","year":"2023","unstructured":"Nakamura N et al (2023) Altered offspring neurodevelopment in an L-NAME-induced preeclampsia rat model. Front Pediatr 11:1168173. https:\/\/doi.org\/10.3389\/fped.2023.1168173","journal-title":"Front Pediatr"},{"key":"2328_CR26","doi-asserted-by":"publisher","unstructured":"de Alwis, N. et al. The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health. Life Sci Alliance 5 (2022). https:\/\/doi.org\/10.26508\/lsa.202201517","DOI":"10.26508\/lsa.202201517"},{"key":"2328_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41371-021-00637-x","volume":"36","author":"K Chau","year":"2022","unstructured":"Chau K, Welsh M, Makris A, Hennessy A (2022) Progress in preeclampsia: the contribution of animal models. J Hum Hypertens 36:705\u2013710. https:\/\/doi.org\/10.1038\/s41371-021-00637-x","journal-title":"J Hum Hypertens"},{"key":"2328_CR28","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI119388","volume":"99","author":"Y Zhou","year":"1997","unstructured":"Zhou Y, Damsky CH, Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99:2152\u20132164. https:\/\/doi.org\/10.1172\/JCI119388","journal-title":"J Clin Invest"},{"key":"2328_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s11596-009-0617-z","volume":"29","author":"J Xia","year":"2009","unstructured":"Xia J, Qiao F, Su F, Liu H (2009) Implication of expression of osteopontin and its receptor integrin alphanubeta3 in the placenta in the development of preeclampsia. J Huazhong Univ Sci Technolog Med Sci 29:755\u2013760. https:\/\/doi.org\/10.1007\/s11596-009-0617-z","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2328_CR30","doi-asserted-by":"publisher","first-page":"dev200717","DOI":"10.1242\/dev.200717","volume":"149","author":"DL Gumina","year":"2022","unstructured":"Gumina DL et al (2022) Dysregulation of integrin alphavbeta3 and alpha5beta1 impedes migration of placental endothelial cells in fetal growth restriction. Development 149:dev200717. https:\/\/doi.org\/10.1242\/dev.200717","journal-title":"Development"},{"key":"2328_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12964-024-01567-0","volume":"22","author":"SJ Ho","year":"2024","unstructured":"Ho SJ et al (2024) Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor. Cell Commun Signal 22:221. https:\/\/doi.org\/10.1186\/s12964-024-01567-0","journal-title":"Cell Commun Signal"},{"key":"2328_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/wrna.115","volume":"3","author":"S Ramachandran","year":"2012","unstructured":"Ramachandran S, Palanisamy V (2012) Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 3:286\u2013293. https:\/\/doi.org\/10.1002\/wrna.115","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2328_CR33","doi-asserted-by":"publisher","first-page":"e1001604","DOI":"10.1371\/journal.pbio.1001604","volume":"11","author":"C Fruhbeis","year":"2013","unstructured":"Fruhbeis C et al (2013) Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604. https:\/\/doi.org\/10.1371\/journal.pbio.1001604","journal-title":"PLoS Biol"},{"key":"2328_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jnci\/58.2.209","volume":"58","author":"J Fogh","year":"1977","unstructured":"Fogh J, Wright WC, Loveless JD (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58:209\u2013214. https:\/\/doi.org\/10.1093\/jnci\/58.2.209","journal-title":"J Natl Cancer Inst"},{"key":"2328_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","volume":"59","author":"J Fogh","year":"1977","unstructured":"Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221\u2013226. https:\/\/doi.org\/10.1093\/jnci\/59.1.221","journal-title":"J Natl Cancer Inst"},{"key":"2328_CR36","first-page":"3562","volume":"57","author":"JE Landers","year":"1997","unstructured":"Landers JE, Cassel SL, George DL (1997) Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res 57:3562\u20133568","journal-title":"Cancer Res"},{"key":"2328_CR37","doi-asserted-by":"publisher","first-page":"18743","DOI":"10.1074\/jbc.273.30.18743","volume":"273","author":"D Yeagley","year":"1998","unstructured":"Yeagley D, Agati JM, Quinn PG (1998) A tripartite array of transcription factor binding sites mediates cAMP induction of phosphoenolpyruvate carboxykinase gene transcription and its inhibition by insulin. J Biol Chem 273:18743\u201318750. https:\/\/doi.org\/10.1074\/jbc.273.30.18743","journal-title":"J Biol Chem"},{"key":"2328_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.placenta.2020.12.013","volume":"104","author":"B Dietrich","year":"2021","unstructured":"Dietrich B, Kunihs V, Haider S, Pollheimer J, Knofler M (2021) 3-dimensional JEG-3 choriocarcinoma cell organoids as a model for trophoblast expansion and differentiation. Placenta 104:243\u2013246. https:\/\/doi.org\/10.1016\/j.placenta.2020.12.013","journal-title":"Placenta"},{"key":"2328_CR39","doi-asserted-by":"publisher","first-page":"1130308","DOI":"10.3389\/fimmu.2023.1130308","volume":"14","author":"BM Zhuang","year":"2023","unstructured":"Zhuang BM et al (2023) Application of a JEG-3 organoid model to study HLA-G function in the trophoblast. Front Immunol 14:1130308. https:\/\/doi.org\/10.3389\/fimmu.2023.1130308","journal-title":"Front Immunol"},{"key":"2328_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1006\/geno.2002.6712","volume":"79","author":"MY Chou","year":"2002","unstructured":"Chou MY, Li HC (2002) Genomic organization and characterization of the human type XXI collagen (COL21A1) gene. Genomics 79:395\u2013401. https:\/\/doi.org\/10.1006\/geno.2002.6712","journal-title":"Genomics"},{"key":"2328_CR41","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.254920","author":"K Tsuji-Tamura","year":"2021","unstructured":"Tsuji-Tamura K, Morino-Koga S, Suzuki S, Ogawa M (2021) The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.254920","journal-title":"J Cell Sci"},{"key":"2328_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.112.300318","volume":"33","author":"PH Huang","year":"2013","unstructured":"Huang PH et al (2013) Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells. Arterioscler Thromb Vasc Biol 33:709\u2013717. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300318","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2328_CR43","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1167\/iovs.08-2209","volume":"49","author":"PH Chu","year":"2008","unstructured":"Chu PH et al (2008) Deletion of the FHL2 gene attenuating neovascularization after corneal injury. Invest Ophthalmol Vis Sci 49:5314\u20135318. https:\/\/doi.org\/10.1167\/iovs.08-2209","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2328_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13048-025-01736-w","volume":"18","author":"Y Li","year":"2025","unstructured":"Li Y, Zhang L, Lv H, Mei C, Hu M (2025) BFGF mitigates CTX-induced ovarian cytotoxicity via SERPINE1\/HIF-1 and Nrf-2\/HO-1 signaling pathways. J Ovarian Res 18:151. https:\/\/doi.org\/10.1186\/s13048-025-01736-w","journal-title":"J Ovarian Res"},{"key":"2328_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2011.06.010","volume":"145","author":"AJ Ridley","year":"2011","unstructured":"Ridley AJ (2011) Life at the leading edge. Cell 145:1012\u20131022. https:\/\/doi.org\/10.1016\/j.cell.2011.06.010","journal-title":"Cell"},{"key":"2328_CR46","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1038\/s41467-022-33174-3","volume":"13","author":"B Ding","year":"2022","unstructured":"Ding B et al (2022) Structures reveal a key mechanism of WAVE regulatory complex activation by Rac1 GTPase. Nat Commun 13:5444. https:\/\/doi.org\/10.1038\/s41467-022-33174-3","journal-title":"Nat Commun"},{"key":"2328_CR47","doi-asserted-by":"publisher","first-page":"eadd1412","DOI":"10.1126\/sciadv.add1412","volume":"8","author":"S Yang","year":"2022","unstructured":"Yang S et al (2022) Arf GTPase activates the WAVE regulatory complex through a distinct binding site. Sci Adv 8:eadd1412. https:\/\/doi.org\/10.1126\/sciadv.add1412","journal-title":"Sci Adv"},{"key":"2328_CR48","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1038\/ncomms8465","volume":"6","author":"FK Huang","year":"2015","unstructured":"Huang FK et al (2015) Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization. Nat Commun 6:7465. https:\/\/doi.org\/10.1038\/ncomms8465","journal-title":"Nat Commun"},{"key":"2328_CR49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cell.2009.11.035","volume":"139","author":"CP Petersen","year":"2009","unstructured":"Petersen CP, Reddien PW (2009) Wnt signaling and the polarity of the primary body axis. Cell 139:1056\u20131068. https:\/\/doi.org\/10.1016\/j.cell.2009.11.035","journal-title":"Cell"},{"key":"2328_CR50","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K (2012) The many faces and functions of beta-catenin. EMBO J 31:2714\u20132736. https:\/\/doi.org\/10.1038\/emboj.2012.150","journal-title":"EMBO J"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02328-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:46:43Z","timestamp":1777592803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02328-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02328-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval of the animal protocols was provided by the Committee on the Ethics of Animal Experiments of Xiangya Hospital. All animal experiments were conducted at Xiangya Hospital following the Guiding Principles for the Care and Use of Experimental Animals. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}